These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 9818941)
1. Seasonal variation of interferon-gamma production in progressive multiple sclerosis. Balashov KE; Olek MJ; Smith DR; Khoury SJ; Weiner HL Ann Neurol; 1998 Nov; 44(5):824-8. PubMed ID: 9818941 [TBL] [Abstract][Full Text] [Related]
2. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment]. Bongioanni P; Romano MR; Boccardi B; Lombardo F; Moscato G; Mosti S; Baldini C; Nuti S; Meucci G; Rossi B Rev Neurol; 1999 Nov 16-30; 29(10):893-9. PubMed ID: 10637835 [TBL] [Abstract][Full Text] [Related]
3. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis. Hamamcioglu K; Reder AT Mult Scler; 2007 May; 13(4):459-70. PubMed ID: 17463069 [TBL] [Abstract][Full Text] [Related]
4. Natural cytotoxic activity in multiple sclerosis patients: defects in IL-2/interferon gamma-regulatory circuit. Braakman E; van Tunen A; Meager A; Lucas CJ Clin Exp Immunol; 1986 Nov; 66(2):285-94. PubMed ID: 2949897 [TBL] [Abstract][Full Text] [Related]
5. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b. Ochi H; Feng-Jun M; Osoegawa M; Minohara M; Murai H; Taniwaki T; Kira J J Neurol Sci; 2004 Jul; 222(1-2):65-73. PubMed ID: 15240198 [TBL] [Abstract][Full Text] [Related]
6. Synergistic immune responses induced by endogenous retrovirus and herpesvirus antigens result in increased production of inflammatory cytokines in multiple sclerosis patients. Brudek T; Christensen T; Hansen HJ; Petersen T; Møller-Larsen A Scand J Immunol; 2008 Mar; 67(3):295-303. PubMed ID: 18261041 [TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma secretion by peripheral blood T-cell subsets in multiple sclerosis: correlation with disease phase and interferon-beta therapy. Becher B; Giacomini PS; Pelletier D; McCrea E; Prat A; Antel JP Ann Neurol; 1999 Feb; 45(2):247-50. PubMed ID: 9989628 [TBL] [Abstract][Full Text] [Related]
9. Role of decreased production of interleukin-10 and interferon-gamma in spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes in vitro. Djurdjevic P; Zelen I; Ristic P; Baskic D; Popovic S; Arsenijevic N Arch Med Res; 2009 Jul; 40(5):357-63. PubMed ID: 19766898 [TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma and interleukin-4-producing T cells in peripheral blood of multiple sclerosis patients. Franciotta D; Zardini E; Bergamaschi R; Andreoni L; Cosi V Eur Cytokine Netw; 2000 Dec; 11(4):677-81. PubMed ID: 11125313 [TBL] [Abstract][Full Text] [Related]
11. [Interferon production and natural killer activity of peripheral blood lymphocytes obtained from patients with multiple sclerosis]. Maruo Y Hokkaido Igaku Zasshi; 1988 Jul; 63(4):521-33. PubMed ID: 2464533 [TBL] [Abstract][Full Text] [Related]
12. Correlation between disease severity and in vitro cytokine production mediated by MSRV (multiple sclerosis associated retroviral element) envelope protein in patients with multiple sclerosis. Rolland A; Jouvin-Marche E; Saresella M; Ferrante P; Cavaretta R; Créange A; Marche P; Perron H J Neuroimmunol; 2005 Mar; 160(1-2):195-203. PubMed ID: 15710473 [TBL] [Abstract][Full Text] [Related]
13. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis. Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209 [TBL] [Abstract][Full Text] [Related]
14. Contrasting effects of alpha, beta, and gamma interferons on nonspecific suppressor function in multiple sclerosis. Noronha A; Toscas A; Jensen MA Ann Neurol; 1992 Jan; 31(1):103-6. PubMed ID: 1371908 [TBL] [Abstract][Full Text] [Related]
15. Short-term treatment of relapsing remitting multiple sclerosis patients with interferon (IFN)-beta1B transiently increases the blood levels of interleukin (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1beta, IL-2, IL-4 and tumour necrosis factor-alpha. Nicoletti F; Di Marco R; Patti F; Zaccone P; L'Episcopo MR; Reggio E; Xiang M; Nicoletti A; Reggio A Cytokine; 2000 Jun; 12(6):682-7. PubMed ID: 10843745 [TBL] [Abstract][Full Text] [Related]
16. Expansion of CD4+CD28- T cells producing high levels of interferon-{gamma} in peripheral blood of patients with multiple sclerosis. Miyazaki Y; Iwabuchi K; Kikuchi S; Fukazawa T; Niino M; Hirotani M; Sasaki H; Onoé K Mult Scler; 2008 Sep; 14(8):1044-55. PubMed ID: 18573819 [TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the genes encoding interferon-gamma and interferon-gamma receptors in multiple sclerosis. Schrijver HM; Hooper-van Veen T; van Belzen MJ; Crusius JB; Peña AS; Barkhof F; Polman CH; Uitdehaag BM Eur J Immunogenet; 2004 Jun; 31(3):133-40. PubMed ID: 15182327 [TBL] [Abstract][Full Text] [Related]
18. Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis. Marckmann S; Wiesemann E; Hilse R; Trebst C; Stangel M; Windhagen A Clin Exp Immunol; 2004 Dec; 138(3):499-506. PubMed ID: 15544628 [TBL] [Abstract][Full Text] [Related]
20. Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS. Chen M; Chen G; Nie H; Zhang X; Niu X; Zang YC; Skinner SM; Zhang JZ; Killian JM; Hong J Eur J Immunol; 2009 Sep; 39(9):2525-36. PubMed ID: 19670379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]